Biotricity stock.

Biotricity had revenue of $11.11M in the twelve months ending September 30, 2023, with 30.50% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $2.89M with 21.41% year-over-year growth. In the fiscal year ending March 31, 2023, Biotricity had annual revenue of $9.64M with 26.00% growth. Revenue (ttm)BTCY - Biotricity Inc - Stock screener for investors and traders, financial visualizations.Common Stock, Par Value $0.001 BTCY Nasdaq Capital Market Securities registered pursuant to Section 12(g) of the Act: Title of Each Class Name of Each Exchange On Which Registered ... Biotricity Inc. (the “Company”, “Biotricity”, “we”, “us”, “our”) is a leading-edge medical technology company focused on biometric data ...Biotricity, Inc. (BTCY) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Add to watchlist 0.9601 -0.0299 (-3.02%) As of 10:23AM EST. Market open. Chart …

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Biotricity, Inc. Common Stock (BTCY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Biotricity Stock Down 4.2 %. Shares of BTCY opened at $0.91 on Monday. The company has a market cap of $7.80 million, a P/E ratio of -0.57 and a beta of 2.34. Biotricity has a one year low of $0.70 and a one year high of $7.44. The stock has a fifty day moving average price of $1.69.Nov 14, 2023 · Biotricity to Implement 1-for-6 Reverse Stock Split; Shares Slump Premarket Jul. 03: MT Biotricity to Implement 1-for-6 Reverse Stock Split Jun. 30: MT Transcript : Biotricity, Inc., 2023 Earnings Call, Jun 30, 2023 Jun. 30: CI

Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that it made a 510(k) submission to the U.S.BTCY Stock 12 Months Forecast. ―. Based on 1 Wall Street analysts offering 12 month price targets for Biotricity in the last 3 months. The average price target is ― with a high forecast of ― and a low forecast of ―. The average price target represents a ― change from the last price of $0.92. Highest Price Target ―.Biotricity had revenue of $11.11M in the twelve months ending September 30, 2023, with 30.50% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $2.89M with 21.41% year-over-year growth. In the fiscal year ending March 31, 2023, Biotricity had annual revenue of $9.64M with 26.00% growth. Revenue (ttm)Biotricity stock rises on surpassing $10M in annual revenue run rate SA News Mon, Nov. 21, 2022. Biotricity GAAP EPS of -$0.09 misses by $0.01, revenue of $2.4M misses by $0.14M

Stock Price. 0.99. About Biotricity. Biotricity is a medical technology company that operates in the digital health sector. The company's primary offerings ...

Biotricity is trading at 0.62 as of the 2nd of May 2023; that is 10.71 percent up since the beginning of the trading day. The stock's open price was 0.56. Stay informed about Biotricity Stock and gain insights into the value of trading Biotricity now. Get the latest Biotricity detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biotricity Stock ...

Biotricity achieves $14 Million Revenue Run Rate in August 2023; Biotricity reports strong growth for its first quarter fiscal year 2024 and provides financial results and business updates; Biotricity to host first quarter Fiscal Year 2024 financial results and business update call on August 15thBiotricity Stock Forecast, BTCY stock price prediction. Price target in 14 days: 1.097 USD. The best long-term & short-term Biotricity share price prognosis ...Track Biotricity Inc (BTCY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the …Biotricity, Inc. (BTCY) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.9200 -0.0300 (-3.16%) As of 11:29AM EST. Market open. 1d 5d 1m 6m YTD 1y 5y Max Full screen REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology c...The 67 rating InvestorsObserver gives to Biotricity Inc ( BTCY) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 95 percent of stocks in the Medical Devices industry, BTCY’s 67 overall rating means the stock scores better than 67 percent of all stocks. BTCY has an Overall Score of 67.Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 8,768,650 shares of Common Stock, $0.001 par value, at November 13, 2023. As at that same date, the Company also has 244,453 Exchangeable

Biotricity Stock Forecast, BTCY stock price prediction. Price target in 14 days: 1.097 USD. The best long-term & short-term Biotricity share price prognosis ...30 Haz 2023 ... Biotricity Holdings (BTCY) said on Friday that it will effect a reverse stock split of it common stock, effective after markets open on July ...How can I reach the investor relations department? For more information, please feel free to reach out to: Biotricity Investor Relations. 1.800.590.4155. [email protected]. KCSA Strategic Communications. Valter Pinto or Jack Perkins. [email protected]. 1-212-896-1254.Biotricity story: Community Health Systems,Inc , 5 Value Stocks In The Healthcare Sector Benzinga and other headlines for BiotricityREDWOOD CITY, Calif., Aug 26, 2021 (ACCESSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public offering of 5,000,000 shares of common stock of the Company, at a price of $3.00 per share for total gross proceeds to the Company of approximately $15 million.Biotricity ( NASDAQ: BTCY) is a remote health monitoring company specializing in heart monitoring with a big market in front of it. It has produced its own products, leveraging its core technology ...17 Tem 2023 ... ... stock and warrants. Biotricity, Inc. Biotricity (Nasdaq: BTCY) is a medical technology company focused on delivering remote biometric ...

Biotricity, Inc. (BTCY) Stock Price, Quote & News - Stock Analysis 0.925 +0.045 (5.07%) Nov 24, 2023, 4:00 PM EST - Market 5.07 About BTCY Financial Performance In 2022, Biotricity's revenue was $9.64 million, an increase of 26.00% compared to the previous year's $7.65 million. Losses were -$19.53 million, -35.36% less than in 2021. News All VideosStock Price Forecast. According to 1 stock analyst, the 12-month stock price forecast for Biotricity stock is $4.00, which predicts an increase of 327.67%. On average, analysts rate Biotricity stock as a strong buy.

October 10, 2023 at 8:15 AM · 5 min read. Biotricity, Inc. REDWOOD CITY, CA / ACCESSWIRE / October 10, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in ...Stock Price. 0.99. About Biotricity. Biotricity is a medical technology company that operates in the digital health sector. The company's primary offerings ...Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th AccessWire - Mon May 23, 2022 . REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present and... Track Biotricity Inc (BTCY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the …REDWOOD CITY, CA / ACCESSWIRE / November 14, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its financial results for the second quarter of fiscal 2024 year and (unaudited) ended September 30, 2023.Biotricity, Inc. 0.9307. -0.0193. -2.03%. Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, provided a recap of its ...May 16, 2023 · REDWOOD CITY, Calif., May 16, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a leading medical diagnostic and consumer healthcare technology company, today reported that it reached a record $13 million annualized revenue run rate in April — further extending its growth by over eight percent from the $12 million run rate it announced for March 2023. 30 Haz 2023 ... Biotricity expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on ...BTCY Stock 12 Months Forecast. ―. Based on 1 Wall Street analysts offering 12 month price targets for Biotricity in the last 3 months. The average price target is ― with a high forecast of ― and a low forecast of ―. The average price target represents a ― change from the last price of $0.92. Highest Price Target ―. https://www.biotricity.com. Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

MT. HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating. Jul. 07. MT. HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating. Jul. 05. MT. Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating. 2022.

MT. HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating. Jul. 07. MT. HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating. Jul. 05. MT. Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating. 2022.

According to analytics firm InfoTrie Financial Solutions’ Sentiment Analysis, based on their scoring system, Biotricity’s news buzz score a 10 out of 10, with a market sentiment score of 4.0.May 16, 2023 · Consumer healthcare technology company Biotricity ( NASDAQ: BTCY) said on Tuesday that its April annualized revenue run rate reached $13M, compared to the $12M run rate for March. The company ... REDWOOD CITY, Calif., Aug 25, 2021 (ACCESSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the Company expects to grant the underwriter of the offering a 30-day ...A high-level overview of Biotricity, Inc. (BTCY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Biotricity Stock Forecast, BTCY stock price prediction. Price target in 14 days: 1.097 USD. The best long-term & short-term Biotricity share price prognosis ...Aug 31, 2021 · peepo/E+ via Getty Images. Shares of Biotricity ( NASDAQ: BTCY) have been on fire since I re-introduced the Seeking Alpha community to the company in my February 2021 article. Shares reached a 52 ... The table below includes insider transactions amounts, trade dates and executives completing transactions. Biotricity insider trades include the CEO, CFO, board of directors and is updated today.Related Stock Lists: Disease Medicine Alzheimer's Disease Biotechnology Chronic Pain ... Biotricity, Inc. (BTCY) Q2 2024 Earnings Call Transcript. Nov 14, BTCY ...Biotres Pro continues this trend and establishes Biotricity's product portfolio as the most comprehensive remote cardiac monitoring product portfolio globally. Biotres is a unique innovative ECG ...Nov 29, 2023 · Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components.

Mar 7, 2023 · AT&T stock has slumped in 2023, and director Stephen J. Luczo recently bought a large block of shares of the media and telecom firm. AT&T stock (ticker: T) has dropped about 12% this year, while ... Biotricity Stock Down 3.3 %. NASDAQ:BTCY opened at $0.88 on Wednesday. The company has a market capitalization of $7.54 million, a price-to-earnings ratio of -0.55 and a beta of 2.34. The firm’s 50-day moving average is $1.67. Biotricity has a 52-week low of $0.70 and a 52-week high of $7.44. About BiotricityDiscover historical prices for BTCY stock on Yahoo Finance. View daily, weekly or monthly format back to when Biotricity, Inc. stock was issued.Instagram:https://instagram. largest office reitsnasdaq rxrxitko stockdental insurance plans in pa Biotricity exhibits very low volatility with skewness of -1.52 and kurtosis of 8.41. However, we advise investors to further study Biotricity technical ...Biotricity, Inc. ( NASDAQ:BTCY ) shareholders might understandably be very concerned that the share price has dropped... wvvishot spotter stock Find the latest Biotricity, Inc. (BTCY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Email Registration. Or log in with cigna corp stock Dec 1, 2023 · Stock analysis for Biotricity Inc (BTCY:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 30 Haz 2023 ... Biotricity expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on ...